Skip to main content
Caplight Logo









AskGene Pharma

AskGene Pharma

Private
Camarillo, CaliforniaHealthcare & Life Scienceshttps://ask-gene.com/

Last Round

Private Placement

Oct 16, 2024

Total Funding Raised

$20M

Company Overview

AskGene Pharma is a biotechnology company that develops next-generation cytokine therapeutics for oncology and autoimmune disease treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

cytokine therapeuticscytokine prodrug platformantibody-cytokine fusionimmuno-oncologyprodrug technologyclinical-stage biotechtargeted drug deliverymonoclonal antibodymAbCLDN18.2 targetbispecific antibodyIL-15 therapydrug licensingprotein engineeringautoimmune disease therapyophthalmology therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AskGene Pharma Comparables

Compare AskGene Pharma with similar companies based on industry and business-model similarity.

AskGene Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Proviva Therapeutics
83%
Synthekine
81%
Werewolf Therapeutics
81%

AskGene Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementOct 16, 2024
Series AMay 8, 2022

AskGene Pharma Investors

Notable investors and investment history

AskGene Pharma investors
InvestorRounds
TF CapitalPrivate Placement, Series A
Qiming Venture PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors grew 93% MoM.

  • Nov 12, 2025

    Monthly visitors increased 129% MoM, reaching 797.

AskGene Pharma Filings

Explore SEC and related filing metadata, where available.

AskGene Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AskGene Pharma's valuation, stock price, and market status.

Is AskGene Pharma a public or private company?

AskGene Pharma is a private company.

What is the current stock price of AskGene Pharma?

AskGene Pharma is a private company with no public stock price. No recent secondary market data is available.

How much is AskGene Pharma worth (valuation)?

Valuation information for AskGene Pharma is not publicly available.

Can I buy AskGene Pharma stock?

AskGene Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AskGene Pharma's last funding round?

AskGene Pharma's most recent funding round was Private Placement on October 16, 2024.

Who are the main investors in AskGene Pharma?

Key investors in AskGene Pharma include TF Capital, Qiming Venture Partners.

Will AskGene Pharma IPO soon?

No public IPO plans have been announced for AskGene Pharma.

How can I track AskGene Pharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AskGene Pharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCamarillo, California
Employee Range9
Year Founded2012
Last FundingOct 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?